Moderna (MRNA) Guides FY23 Covid-19 Vax Revenue of $6B-$8B
Tweet
Share
E-mail
Get Alerts MRNA Hot Sheet
Join SI Premium – FREE
Moderna (MRNA) Guides FY23 Covid-19 Vax Revenue of $6B-$8B
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Moderna Wins Fda Panel Backing For Mrna Flu Vaccine
- Moderna Announces FDA Advisory Committee Votes Unanimously in Favor of the Benefit-Risk Profile of mRNA-1010, an Investigational Seasonal Influenza Vaccine
- Moderna's mRNA flu vaccine backed by FDA advisers
Create E-mail Alert Related Categories
Guidance, Hot Guidance, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
